rampant positivity for a down-rampant post. Thanks for balancing the scales jrslim.
The question is not whether our technology will be used at all but whether clinical trials will yield the desired outcomes and whether the product will suit the target market jrslim.
price this time next year ?, page-34
Add WFL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| WFL (ASX) Chart |
Day chart unavailable